Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neutralization Tests"" wg kryterium: Temat


Tytuł:
Precision and correlation of ED 50 and endpoint titer method in measuring HPV vaccine immunogenicity.
Autorzy:
Qiu D; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Public Health, Xiamen University, Xiamen, Fujian 361102, PR China.
Liu Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Public Health, Xiamen University, Xiamen, Fujian 361102, PR China.
Wang Z; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, PR China.
Zhang Z; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Public Health, Xiamen University, Xiamen, Fujian 361102, PR China.
Nie M; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Public Health, Xiamen University, Xiamen, Fujian 361102, PR China.
Xia N; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Public Health, Xiamen University, Xiamen, Fujian 361102, PR China; Xiang An Biomedicine Laboratory, Xiamen, Fujian 361102, PR China; The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, PR China.
Li S; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, Fujian 361102, PR China; School of Public Health, Xiamen University, Xiamen, Fujian 361102, PR China; Xiang An Biomedicine Laboratory, Xiamen, Fujian 361102, PR China. Electronic address: .
Zhao Q; College of Pharmacy, Chongqing Medical University, Chongqing 400016, PR China. Electronic address: .
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2023 Jun; Vol. 316, pp. 114716. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Papillomavirus Vaccines*/classification
Papillomavirus Vaccines*/immunology
Enzyme-Linked Immunosorbent Assay*/methods
Neutralization Tests*/methods
Correlation of Data*
Immunogenicity, Vaccine*/immunology
Humans ; Male ; Female ; Young Adult ; Adult ; Antibodies, Neutralizing/immunology ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
Autorzy:
Erfanpoor, Saeed (AUTHOR)
Banihashemi, Seyed Reza (AUTHOR)
Mokhbaeralsafa, Ladan (AUTHOR)
Kalantari, Saeed (AUTHOR)
Es-haghi, Ali (AUTHOR)
Nofeli, Mojtaba (AUTHOR)
Rezaei Mokarram, Ali (AUTHOR)
Sadeghi, Fariba (AUTHOR)
Hajimoradi, Monireh (AUTHOR)
Razaz, Seyad Hossein (AUTHOR)
Taghdiri, Maryam (AUTHOR)
Lotfi, Mohsen (AUTHOR)
Khorasani, Akbar (AUTHOR)
Ansarifar, Akram (AUTHOR)
Masoumi, Safdar (AUTHOR)
Mohazzab, Arash (AUTHOR)
Filsoof, Sara (AUTHOR)
Mohseni, Vahideh (AUTHOR)
Shahsavan, Masoumeh (AUTHOR)
Gharavi, Niloufar (AUTHOR)
Pokaż więcej
Źródło:
BMC Medicine. 2/20/2024, Vol. 22 Issue 1, p1-11. 11p.
Czasopismo naukowe
Tytuł:
Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice.
Autorzy:
Dashti N; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Golsaz-Shirazi F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Jeddi-Tehrani M; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Zarnani AH; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.; Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Amiri MM; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Iranian journal of immunology : IJI [Iran J Immunol] 2024 Mar 12; Vol. 21 (1), pp. 1-14. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Viral Vaccines*
Humans ; Animals ; Mice ; Female ; COVID-19 Vaccines ; Antibodies, Neutralizing ; SARS-CoV-2 ; Antibodies, Viral ; Mice, Inbred BALB C ; Neutralization Tests
Czasopismo naukowe
Tytuł:
A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns.
Autorzy:
Chumbe A; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Grobben M; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Capella-Pujol J; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Koekkoek SM; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Zon I; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Slamanig S; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Merat SJ; AIMM Therapeutics, Amsterdam, the Netherlands.
Beaumont T; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands; AIMM Therapeutics, Amsterdam, the Netherlands.
Sliepen K; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Schinkel J; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands. Electronic address: .
van Gils MJ; Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands. Electronic address: .
Pokaż więcej
Źródło:
Virus research [Virus Res] 2024 Mar; Vol. 341, pp. 199308. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C*
Vaccines*
Humans ; Hepacivirus ; Antibodies, Neutralizing ; Antibody Formation ; Neutralization Tests ; Viral Envelope Proteins ; Glycoproteins ; Epitopes ; Hepatitis C Antibodies ; Antibodies, Monoclonal
Czasopismo naukowe
Tytuł:
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
Autorzy:
Zhang F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
Schmidt F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
Muecksch F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
Wang Z; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
Gazumyan A; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA.
Nussenzweig MC; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA.
Gaebler C; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
Caskey M; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
Hatziioannou T; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
Bieniasz PD; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Feb 14; Vol. 15 (2), pp. e0167223. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*
Humans ; Spike Glycoprotein, Coronavirus ; Antibodies, Viral ; Glycosylation ; COVID-19 Serotherapy ; Antibodies, Neutralizing ; Polysaccharides ; Neutralization Tests
Czasopismo naukowe
Tytuł:
Microfluidic-assisted single-cell RNA sequencing facilitates the development of neutralizing monoclonal antibodies against SARS-CoV-2.
Autorzy:
Wang Z; School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Huang AS; Dalton Academy, The Affiliated High School of Peking University, Beijing, 100190, China.
Tang L; Dalton Academy, The Affiliated High School of Peking University, Beijing, 100190, China.
Wang J; School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Wang G; Institute for Cell Analysis, Shenzhen Bay Laboratory, Shenzhen, 518132, China. .
Pokaż więcej
Źródło:
Lab on a chip [Lab Chip] 2024 Feb 13; Vol. 24 (4), pp. 642-657. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*
Humans ; SARS-CoV-2/genetics ; Neutralization Tests ; Antibodies, Monoclonal/metabolism ; Microfluidics ; Sequence Analysis, RNA ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.
Autorzy:
Avila-Herrera A; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Kimbrel JA; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Manuel Martí J; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Thissen J; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Saada EA; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Weisenberger T; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Arrildt KT; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Segelke BW; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Allen JE; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Zemla A; Lawrence Livermore National Laboratory, Computing Directorate, Global Security Computing Applications Division, Livermore, California, United States of America.
Borucki MK; Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Biosciences and Biotechnology Division, Livermore, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 25; Vol. 19 (1), pp. e0289198. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*
Humans ; SARS-CoV-2/genetics ; Antibodies, Viral ; Neutralization Tests ; Immune Sera ; Spike Glycoprotein, Coronavirus/genetics
Czasopismo naukowe
Tytuł:
Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects.
Autorzy:
Fajfr M; Institute of Clinical Microbiology, University Hospital in Hradec Kralove, Sokolska 581, Hradec Kralove, 50005, Czech Republic.; Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
Pajer P; Military Health Institute, Prague, Czech Republic.
Ruzek D; Department of Virology, Veterinary Research Institute, Brno, Czech Republic.; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic.; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
Sleha R; Department of Epidemiology, Military Faculty of Medicine, University of Defence, Hradec Kralove, Czech Republic.
Janovska S; Department of Epidemiology, Military Faculty of Medicine, University of Defence, Hradec Kralove, Czech Republic.
Bohonek M; Department of Hematology and Blood Transfusion, Military University Hospital Prague, Praha, Czech Republic.; Faculty of Biomedical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
Kabickova H; Military Health Institute, Prague, Czech Republic.
Kubicková P; Military Health Institute, Prague, Czech Republic.
Stefanik M; Department of Virology, Veterinary Research Institute, Brno, Czech Republic.; Department of Hematology and Blood Transfusion, Military University Hospital Prague, Praha, Czech Republic.
Strakova P; Department of Virology, Veterinary Research Institute, Brno, Czech Republic.; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic.; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
Bostik P; Institute of Clinical Microbiology, University Hospital in Hradec Kralove, Sokolska 581, Hradec Kralove, 50005, Czech Republic. .; Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1421. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/diagnosis
Humans ; Serologic Tests/methods ; Sensitivity and Specificity ; Antibodies, Viral ; Immunoglobulin G ; Neutralization Tests/methods ; Antibodies, Neutralizing
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Efficient implementation of hepatitis B surface antigen confirmatory neutralization tests.
Autorzy:
Yonezawa H; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Tanaka S; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan. Electronic address: .
Tanaka M; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kobayashi R; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Takahashi S; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Jan; Vol. 30 (1), pp. 29-33. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/diagnosis
Hepatitis B, Chronic*
Humans ; Female ; Hepatitis B Surface Antigens ; Neutralization Tests ; Retrospective Studies ; Serologic Tests/methods ; Hepatitis B virus ; DNA, Viral
Czasopismo naukowe
Tytuł:
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.
Autorzy:
Santos da Silva, Eveline (AUTHOR)
Servais, Jean-Yves (AUTHOR)
Kohnen, Michel (AUTHOR)
Arendt, Vic (AUTHOR)
Staub, Therese (AUTHOR)
Krüger, Rejko (AUTHOR)
Fagherazzi, Guy (AUTHOR)
Wilmes, Paul (AUTHOR)
Hübschen, Judith M. (AUTHOR)
Ollert, Markus (AUTHOR)
Perez-Bercoff, Danielle (AUTHOR)
Seguin-Devaux, Carole (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Oct2023, Vol. 24 Issue 19, p14965. 19p.
Czasopismo naukowe
Tytuł:
Dual-Function Janus Nanozymes for Performance Evaluation and Application in a Surrogate Virus Neutralization Test with Vaccinated Samples.
Autorzy:
Kwak SH; Safety Measurement Institute, Korea Research Institute of Standards and Science, Daejeon 34141, Republic of Korea.
Jeong DG; Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34113, Republic of Korea.
Shon HK; Safety Measurement Institute, Korea Research Institute of Standards and Science, Daejeon 34141, Republic of Korea.
Kim DH; Department of Pediatrics, Korea Cancer Center Hospital, Seoul 01812, Republic of Korea.
Lee TG; Safety Measurement Institute, Korea Research Institute of Standards and Science, Daejeon 34141, Republic of Korea.
Wi JS; Department of Materials Science and Engineering, Hanbat National University, Daejeon 34158, Republic of Korea.
Na HK; Safety Measurement Institute, Korea Research Institute of Standards and Science, Daejeon 34141, Republic of Korea.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2023 Dec 06; Vol. 15 (48), pp. 55975-55983. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Biological Assay*
Middle East Respiratory Syndrome Coronavirus*
Neutralization Tests ; Gold ; Kinetics ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
Autorzy:
Wieczorek L; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Sanders-Buell E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Zemil M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Lewitus E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Kavusak E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Heller J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Molnar S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Smith G; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Bose M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Nguyen A; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Dhungana A; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Okada K; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Parisi K; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Silas D; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Slike B; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Ganesan A; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.; Walter Reed National Military Medical Center, Bethesda, Maryland, United States of America.
Okulicz J; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.; Brooke Army Medical Center, Fort Sam Houston, San Antonio, Texas, United States of America.
Lalani T; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.; Naval Medical Center Portsmouth, Portsmouth, Virginia, United States of America.
Agan BK; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Crowell TA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Darden J; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.; Diagnostics and Countermeasures Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Rolland M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Vasan S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Ake J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Krebs SJ; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Peel S; Diagnostics and Countermeasures Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Tovanabutra S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Polonis VR; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Dec 06; Vol. 19 (12), pp. e1011780. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
HIV Infections*
HIV-1*/genetics
HIV Seropositivity*
Humans ; United States/epidemiology ; HIV Antibodies ; Neutralization Tests ; env Gene Products, Human Immunodeficiency Virus/genetics ; Antibodies, Neutralizing ; Pandemics
Czasopismo naukowe
Tytuł:
Development of a high-throughput flow cytometric neutralization assay to screen for human enterovirus A71 (EVA71) neutralizing antibodies.
Autorzy:
Wongsa A; Center of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Priengprom T; Center of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Saelee J; Center of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Phawong C; Department of Medical Technology, Faculty of Medicine, Western University, Pathum Thani, Thailand.
Tassaneetrithep B; Center of Research Excellence in Immunoregulation, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Electronic address: .
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2023 Dec; Vol. 322, pp. 114828. Date of Electronic Publication: 2023 Sep 30.
Typ publikacji:
Journal Article
MeSH Terms:
Enterovirus*
Enterovirus Infections*
Enterovirus A, Human*
Humans ; Antibodies, Neutralizing ; Reproducibility of Results ; Neutralization Tests/methods ; Antibodies, Viral ; Antigens, Viral
Czasopismo naukowe
Tytuł:
Serological methods for the detection of antibodies against monkeypox virus applicable for laboratories with different biosafety levels.
Autorzy:
Grossegesse M; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Berlin, Germany.
Stern D; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Biological Toxins (ZBS 3), Berlin, Germany.
Hofmann N; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Berlin, Germany.
Surtees R; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Berlin, Germany.
Kohl C; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Berlin, Germany.
Michel J; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Berlin, Germany.
Nitsche A; Robert Koch Institute, Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Berlin, Germany.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2023 Dec; Vol. 95 (12), pp. e29261.
Typ publikacji:
Journal Article
MeSH Terms:
Monkeypox virus*
Containment of Biohazards*
Humans ; Laboratories ; Antibodies, Viral ; Neutralization Tests
Czasopismo naukowe
Tytuł:
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants.
Autorzy:
Ko HL; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.; Department of Microbiology, College of Medical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Lee DK; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.; Department of Microbiology, College of Medical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Kim Y; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea.; Department of Microbiology, College of Medical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Jang HJ; Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Lee YW; Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Lee HY; Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Seok SH; Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Park JW; Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Limb JK; Korea Mouse Phenotyping Center (KMPC), Seoul National University, Seoul, 08826, South Korea.
On DI; Korea Mouse Phenotyping Center (KMPC), Seoul National University, Seoul, 08826, South Korea.; Laboratory of Developmental Biology and Genomics, Research Institute for Veterinary Science, and BK21 Program for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, South Korea.
Yun JW; Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Seoul National University, Seoul, 08826, South Korea.
Lyoo KS; College of Veterinary Medicine, Jeonbuk National University, Iksan, 54596, Republic of Korea.
Song D; Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.
Yeom M; Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.
Lee H; Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea.
Seong JK; Korea Mouse Phenotyping Center (KMPC), Seoul National University, Seoul, 08826, South Korea. .; Laboratory of Developmental Biology and Genomics, Research Institute for Veterinary Science, and BK21 Program for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, South Korea. .; Interdisciplinary Program for Bioinformatics, Program for Cancer Biology and BIO-MAX/N-Bio Institute, Seoul National University, Seoul, 08826, South Korea. .
Lee S; Division of Research Program, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Dec 01; Vol. 20 (1), pp. 285. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*
Humans ; Antibodies, Monoclonal ; Neutralization Tests ; Receptors, Virus/metabolism ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus/chemistry
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort.
Autorzy:
Zhu L; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Mao N; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yi C; Nanjing Infectious Diseases Clinical Medical Center (The Second Hospital of Nanjing, Nanjing University of Chinese Medicine), Nanjing, P.R China.
Simayi A; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Feng J; School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
Feng Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
He M; Nanjing Municipal Center for Disease Control and Prevention, Nanjing, People's Republic of China.
Ding S; Nanjing Municipal Center for Disease Control and Prevention, Nanjing, People's Republic of China.
Wang Y; Yangzhou Center for Disease Control and Prevention, Yangzhou, Pople's Republic of China.
Wang Y; Yangzhou Center for Disease Control and Prevention, Yangzhou, Pople's Republic of China.
Wei M; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Hong J; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Li C; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Tian H; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Zhou L; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Peng J; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Zhang S; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Song C; School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
Jin H; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
Zhu F; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Xu W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao J; The Third People's Hospital of Yangzhou, Yangzhou, People's Republic of China.
Bao C; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2146535.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/prevention & control
Humans ; Prospective Studies ; Neutralization Tests ; Vaccination ; Antibodies, Neutralizing ; Antibodies, Viral
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Development of a proficiency testing program for HPV serology assays used to evaluate antibody responses in vaccine trials.
Autorzy:
Miller C; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Kemp TJ; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Pinto LA; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Electronic address: .
Pokaż więcej
Źródło:
Journal of immunological methods [J Immunol Methods] 2023 Dec; Vol. 523, pp. 113585. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Papillomavirus Infections*/diagnosis
Papillomavirus Infections*/prevention & control
Vaccines*
Papillomavirus Vaccines*
Humans ; Neutralization Tests/methods ; Antibody Formation ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants.
Autorzy:
Lee B; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
Ko JH; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim YC; Division of Infectious Diseases, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
Baek JY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, South Korea.
Park YS; Division of Infectious Diseases, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
Song KH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Kim ES; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Lee KH; Division of Infectious Diseases, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Song YG; Division of Infectious Diseases, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Ahn JY; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Choi JY; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Choi WS; Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea.
Bae S; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim SH; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Jeong HW; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, South Korea.
Lee YJ; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Korea National Institute of Health, Cheongju, South Korea.
Kim HJ; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Korea National Institute of Health, Cheongju, South Korea.
Choi JY; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Korea National Institute of Health, Cheongju, South Korea.
Kim B; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Korea National Institute of Health, Cheongju, South Korea.
Kim SW; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea.
Kwon KT; Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.
Peck KR; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kang ES; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2023 Dec; Vol. 95 (12), pp. e29329.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*/diagnosis
Humans ; Neutralization Tests ; Immunoassay ; Antibodies, Neutralizing ; Antibodies, Viral
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Neutralization capacity of convalescent plasma against SARS-CoV-2 omicron sublineages: Implications for donor selection.
Autorzy:
McGregor R; Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Carlton L; Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Paterson A; Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Hills T; Te Toka Tumai Auckland, Te Whatu Ora (Health New Zealand), Auckland, New Zealand.; Medical Research Institute of New Zealand, Wellington, New Zealand.
Charlewood R; Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland, Auckland, New Zealand.; New Zealand Blood Service, Auckland, New Zealand.
Moreland NJ; Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Pokaż więcej
Źródło:
Vox sanguinis [Vox Sang] 2023 Dec; Vol. 118 (12), pp. 1145-1147. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:
Letter
MeSH Terms:
Donor Selection*
COVID-19*/therapy
Humans ; SARS-CoV-2 ; COVID-19 Serotherapy ; Cell Differentiation ; Antibodies, Viral/therapeutic use ; Antibodies, Neutralizing/therapeutic use ; Neutralization Tests
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies